Raman Urine Fingerprinting to Predict DGF, Assess Renal Allograft Quality, and Monitor Its State of Health.

IF 1.8 4区 医学 Q2 SURGERY
Giuseppe Orlando, Ryan S Senger, Amr Sayed Issa, Romina Seifollahi Asl, Alejandra Mena Gutierrez, Colleen C Jay, Emily K E McCracken, Alan C Farney, Robert J Stratta, Christopher J Webb, Hollie B Davis, Tracy Doty, Gwen McPherson, Alexandra R Monetti, John R Savino, Lori Byers, Mohammad Kazem Fallahzadeh, Amber Reeves-Daniel, Natalia V Sakhovskaja, Amish Asthana, Barbara K Yoza, Benedetta Bussolati, Alexei V Mikhailov, Emma Peveri, Christopher L Schaich, Lacey Ngo, Fred Gage, Robert Fisher, John Robertson
{"title":"Raman Urine Fingerprinting to Predict DGF, Assess Renal Allograft Quality, and Monitor Its State of Health.","authors":"Giuseppe Orlando, Ryan S Senger, Amr Sayed Issa, Romina Seifollahi Asl, Alejandra Mena Gutierrez, Colleen C Jay, Emily K E McCracken, Alan C Farney, Robert J Stratta, Christopher J Webb, Hollie B Davis, Tracy Doty, Gwen McPherson, Alexandra R Monetti, John R Savino, Lori Byers, Mohammad Kazem Fallahzadeh, Amber Reeves-Daniel, Natalia V Sakhovskaja, Amish Asthana, Barbara K Yoza, Benedetta Bussolati, Alexei V Mikhailov, Emma Peveri, Christopher L Schaich, Lacey Ngo, Fred Gage, Robert Fisher, John Robertson","doi":"10.1111/ctr.70716","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To determine whether Raman spectroscopy-based urine molecular fingerprinting (UMF) may predict delayed graft function (DGF) and assess renal allograft quality prior to transplant and monitor its state of health after transplantation.</p><p><strong>Background: </strong>Current methods for assessing the quality of the renal allograft at baseline and its state of health post-transplantation are inadequate.</p><p><strong>Methods: </strong>We conducted a pilot study in 26 patients receiving DCD allografts. UMF was performed on urine samples collected from study participants immediately before transplantation (baseline), on postoperative day 1-3, and monthly thereafter. UMF findings were correlated with clinical and laboratory data. Primary endpoint was identification of a DGF fingerprint. Secondary endpoints were identification of fingerprints for acute rejection, CMV, BK and eGFR.</p><p><strong>Results: </strong>DGF was observed in 58% of our patients. UMF fingerprints from patients with DGF were distinct from UMF fingerprints of non-DGF patients. Notably, UMF analysis of baseline urine samples from patients prior to transplantation also predicted development of DGF. A correlation of UMF with eGFR was observed, whereas we did not identify fingerprints specific for rejection, CMV or BK possibly due to the small patient population.</p><p><strong>Conclusions: </strong>In this exploratory study, UMF predicts DGF prior to transplantation and provides information on the state of health of the allograft following transplantation.</p>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 10","pages":"e70716"},"PeriodicalIF":1.8000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ctr.70716","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: To determine whether Raman spectroscopy-based urine molecular fingerprinting (UMF) may predict delayed graft function (DGF) and assess renal allograft quality prior to transplant and monitor its state of health after transplantation.

Background: Current methods for assessing the quality of the renal allograft at baseline and its state of health post-transplantation are inadequate.

Methods: We conducted a pilot study in 26 patients receiving DCD allografts. UMF was performed on urine samples collected from study participants immediately before transplantation (baseline), on postoperative day 1-3, and monthly thereafter. UMF findings were correlated with clinical and laboratory data. Primary endpoint was identification of a DGF fingerprint. Secondary endpoints were identification of fingerprints for acute rejection, CMV, BK and eGFR.

Results: DGF was observed in 58% of our patients. UMF fingerprints from patients with DGF were distinct from UMF fingerprints of non-DGF patients. Notably, UMF analysis of baseline urine samples from patients prior to transplantation also predicted development of DGF. A correlation of UMF with eGFR was observed, whereas we did not identify fingerprints specific for rejection, CMV or BK possibly due to the small patient population.

Conclusions: In this exploratory study, UMF predicts DGF prior to transplantation and provides information on the state of health of the allograft following transplantation.

拉曼尿指纹技术预测DGF,评估同种异体肾移植质量,并监测其健康状态。
目的:确定基于拉曼光谱的尿分子指纹(UMF)是否可以预测移植延迟功能(DGF),评估移植前的同种异体肾移植质量,并监测移植后的健康状态。背景:目前评估同种异体肾移植的基线质量和移植后健康状况的方法是不充分的。方法:我们对26例接受同种异体DCD移植的患者进行了初步研究。在移植前(基线)、术后第1-3天以及之后每月对研究参与者收集的尿液样本进行UMF。UMF结果与临床和实验室数据相关。主要终点是DGF指纹的识别。次要终点是鉴定急性排斥反应、CMV、BK和eGFR的指纹。结果:58%的患者出现DGF。DGF患者的UMF指纹与非DGF患者的UMF指纹明显不同。值得注意的是,移植前患者基线尿液样本的UMF分析也预测了DGF的发展。观察到UMF与eGFR的相关性,然而由于患者人数少,我们没有识别出排斥反应、CMV或BK的特异性指纹。结论:在这项探索性研究中,UMF预测移植前的DGF,并提供移植后同种异体移植物健康状况的信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Transplantation
Clinical Transplantation 医学-外科
CiteScore
3.70
自引率
4.80%
发文量
286
审稿时长
2 months
期刊介绍: Clinical Transplantation: The Journal of Clinical and Translational Research aims to serve as a channel of rapid communication for all those involved in the care of patients who require, or have had, organ or tissue transplants, including: kidney, intestine, liver, pancreas, islets, heart, heart valves, lung, bone marrow, cornea, skin, bone, and cartilage, viable or stored. Published monthly, Clinical Transplantation’s scope is focused on the complete spectrum of present transplant therapies, as well as also those that are experimental or may become possible in future. Topics include: Immunology and immunosuppression; Patient preparation; Social, ethical, and psychological issues; Complications, short- and long-term results; Artificial organs; Donation and preservation of organ and tissue; Translational studies; Advances in tissue typing; Updates on transplant pathology;. Clinical and translational studies are particularly welcome, as well as focused reviews. Full-length papers and short communications are invited. Clinical reviews are encouraged, as well as seminal papers in basic science which might lead to immediate clinical application. Prominence is regularly given to the results of cooperative surveys conducted by the organ and tissue transplant registries. Clinical Transplantation: The Journal of Clinical and Translational Research is essential reading for clinicians and researchers in the diverse field of transplantation: surgeons; clinical immunologists; cryobiologists; hematologists; gastroenterologists; hepatologists; pulmonologists; nephrologists; cardiologists; and endocrinologists. It will also be of interest to sociologists, psychologists, research workers, and to all health professionals whose combined efforts will improve the prognosis of transplant recipients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书